Clinical, molecular genetics and therapeutic aspects of syndromic obesity.
All,
This review explains that 16p11.2 deletions are one of several genetic conditions linked to syndromic obesity, and it highlights how genetic testing and precise diagnosis can help families and clinicians choose more individualized, appropriate treatments rather than using generic weight‑management approaches.